Pill aims to restore Body's own insulin in type 1 diabetes
NCT ID NCT06152042
Summary
This study tested whether an oral pill called BMF-219 could help the body produce its own insulin in adults with type 1 diabetes. It compared the drug to a placebo over 52 weeks in 37 participants to see if it improved blood sugar control and reduced insulin needs. The trial was terminated early, and its results are not yet publicly available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alliance for Multispecialty Research, LLC.
Norman, Oklahoma, 73069, United States
-
Centricity Research
Toronto, Ontario, Canada
-
Consano Clinical Research, LLC
Shavano Park, Texas, 78231, United States
-
Diabetes & Glandular Disease Clinic, P.A.
San Antonio, Texas, 78229, United States
-
Dr. T.G Elliott Inc. dba BC Diabetes
Vancouver, British Columbia, Canada
-
Lucas Research, Inc.
Morehead City, North Carolina, 28577, United States
-
Manassas Clinical Research Center
Manassas, Virginia, 20110, United States
-
Oceanic Research Group
North Miami Beach, Florida, 33169, United States
-
Texas Diabetes & Endocrinology
Round Rock, Texas, 78681, United States
-
University Diabetes & Endocrine Consultants
Chattanooga, Tennessee, 37411, United States
-
Velocity Clinical Research
Dallas, Texas, 75230, United States
Conditions
Explore the condition pages connected to this study.